Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients

Virchows Archiv

Volumn 457, Issue 3, 2010, Pages 359-368

  Arfaoui, Amira Toumi ^a,c   Kriaa, Lilia Ben Mahmoud ^a   El Hadj, Olfa El Amine ^b   Ben Hmida, Majid A ^a   Khiari, Myriam ^a   Khalfallah, T ^b   Gharbi, Lasaad ^b   Mzabi, Sabeh ^b   Bouraoui, Sadaa ^a,b  

^a UNIVERSITY OF TUNIS   (Tunisia)

^b MONGI SLIM HOSPITAL   (Tunisia)

^c Medecine University Tunis ^*  (Tunisia)

Author keywords

Colorectal Cancer; p73 polymorphism; Prognosis

Indexed keywords

PROTEIN P73; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUNISIA; ADENOCARCINOMA; CASE CONTROL STUDY; COLORECTAL TUMOR; EXON; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOSITY LOSS; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LOSS OF HETEROZYGOSITY; MALE; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS; TUNISIA; KAPLAN-MEIER ESTIMATE;

EID: 77956920669     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0942-4     Document Type: Article

References (36)

1. M Kaghad H Bonnet A Yang, et al. 1997 Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 809 819 1:CAS:528:DyaK2sXlvFKmurY%3D 10.1016/S0092- 8674(00)80540-1 9288759 (Pubitemid 27357971)
2. ER Flores KY Tsai D Crowley, et al. 2002 p63 and p73 are required for p53-dependent apoptosis in response to DNA damage Nature 416 560 564 1:CAS:528:DC%2BD38XivVOnu7o%3D 10.1038/416560a 11932750 (Pubitemid 34288861)
3. XQ Wang WM Ongkeko AW Lau KM Leung RY Poon 2001 A possible role of p73 on the modulation of p53 level through MDM2 Cancer Res 61 1598 1603 1:CAS:528:DC%2BD3MXhvVelur8%3D 11245471
4. M Mai A Yokomizo C Qian, et al. 1998 Activation of p73 silent allele in lung cancer Cancer Res 58 2347 2349 1:CAS:528:DyaK1cXjs12ru7c%3D 9622072
5. H Takahashi S Ichimiya Y Nimura, et al. 1998 Mutation, allelotyping and transcription analyses of the p73 gene in prostatic carcinoma Cancer Res 58 2076 2077 1:CAS:528:DyaK1cXjt12hsbo%3D 9605745
6. A Yokomizo M Mai DJ Tindall, et al. 1999 Overexpression of the wild type p73 gene in human bladder cancer Oncogene 18 1629 1633 1:CAS:528: DyaK1MXhvVylsLk%3D 10.1038/sj.onc.1202474 10102633
7. A Yang N Walker R Bronson, et al. 2000 p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours Nature 404 99 103 1:CAS:528:DC%2BD3cXhvVyqtbo%3D 10.1038/35003607 10716451 (Pubitemid 30143141)
8. UM Moll S Erster A Zaika 2001 p53, p63 and p73-solos, alliances and feuds among family members Biochim Biophys Acta 1552 47 59 1:CAS:528: DC%2BD38XhsFahsrc%3D 11825686
9. J Benard S Douc-Rasy JC Ahomadegbe 2003 TP53 family members and human Cancers Hum Mutat 21 182 191 1:CAS:528:DC%2BD3sXis1yjtr4%3D 10.1002/humu.10172 12619104 (Pubitemid 36292961)
10. PJ Coates 2006 Regulating p73 isoforms in human tumours J Pathol 210 385 389 1:CAS:528:DC%2BD28XhtlGhs7%2FN 10.1002/path.2080 17044134 (Pubitemid 44830597)
11. S Ichimiya Y Nimura H Kageyama, et al. 1999 p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent Oncogene 18 1061 1066 1:CAS:528:DyaK1MXhsVyitbY%3D 10.1038/sj.onc.1202390 10023682 (Pubitemid 29086283)
12. S Nomoto N Haruki M Kondo H Konishi T Takahashi 1998 Search for mutations and examination of allalic expression imbalance of the p73 gene at 1p36.33 in human lung cancers Cancer Res 58 1380 1383 1:CAS:528:DyaK1cXit1eksr4%3D 9537234
13. Y Nimura M Mihara S Ichimiya, et al. 1998 P73, a gene related to p53, is not mutated in esophageal carcinomas Int J Cancer 78 437 440 1:CAS:528:DyaK1cXnsVShtL4%3D 10.1002/(SICI)1097-0215(19981109)78:4<437::AID- IJC8>3.0.CO;2-V 9797131 (Pubitemid 28481161)
14. Y Cai GY Yang Y Nie, et al. 2000 Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53 Carcinogenesis 21 683 689 1:CAS:528:DC%2BD3cXivFKktbs%3D 10.1093/carcin/21.4.683 10753204
15. XF Sun 2002 p73 Overexpression is a prognostic factor in patients with colorectal adenocarcinoma Clin Cancer Res 8 165 170 1:CAS:528: DC%2BD38XhsVKmurY%3D 11801554
16. M Guan HX Peng B Yu Y Lu 2003 p73 overexpression and angiogenesis in human colorectal carcinoma Jpn J Clin Oncol 33 215 220 1:CAS:528: DC%2BD2cXlt1ajsL0%3D 10.1093/jjco/hyg045 12865464 (Pubitemid 43115261)
17. NI Herath MC Kew VL Whitehall, et al. 2000 p73 is up-regulated in a subset of hepatocellular carcinomas Hepatology 31 601 605 1:CAS:528: DC%2BD3cXhvFCqu7k%3D 10.1002/hep.510310309 10706549
18. AI Zaika S Kovalev ND Marchenko, et al. 1999 Overexpression of the wild type p73 gene in breast cancer tissues and cell lines Cancer Res 59 3257 3263 1:CAS:528:DyaK1MXksVGjsbs%3D 10397274
19. N Hamajima K Matsuo T Suzuki, et al. 2002 No association of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphism with the risk of digestive tract cancers in Japanese Cancer Lett 181 81 85 1:CAS:528: DC%2BD38XivVSgurg%3D 10.1016/S0304-3835(02)00041-1 12430182 (Pubitemid 34326437)
20. BM Ryan R McManus JS Daly, et al. 2001 A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma Br J Cancer 85 1499 1503 1:CAS:528:DC%2BD38XkslemsA%3D%3D 10.1054/bjoc.2001.2066 11720435 (Pubitemid 34001580)
21. G Li EM Sturgis LE Wang, et al. 2004 Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck Carcinogenesis 25 1911 1916 1:CAS:528:DC%2BD2cXnvVOqtr4%3D 10.1093/carcin/bgh197 15180941 (Pubitemid 39405910)
22. D Pfeifer G Arbman X-F Sun 2005 Polymorphism of the p73 gene in relation to colorectal cancer risk and survival Carcinogenesis 26 103 107 1:CAS:528:DC%2BD2MXisVSlsQ%3D%3D 10.1093/carcin/bgh305 15485994 (Pubitemid 40207704)
23. A Hiraki K Matsuo N Hamajima, et al. 2003 Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes Asian Pac J Cancer Prev 4 107 112 12875622
24. XE Huang N Hamajima N Katsuda, et al. 2000 Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer Breast Cancer 10 307 311 10.1007/BF02967650
25. Y Niwa N Hamajima Y Atsuta, et al. 2004 Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese Cancer Lett 205 55 60 1:CAS:528:DC%2BD2cXhsVOmtrc%3D 10.1016/j.canlet.2003.11.014 15036661 (Pubitemid 38230139)
26. H Li L Yao T Ouyang, et al. 2007 Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival Carcinogenesis 28 372 377 10.1093/carcin/bgl153 16950799 (Pubitemid 46321853)
27. G Li Li-E Wang RM Chamberlain CI Amos MR Spitz Q Wei 2004 p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer Cancer Res 64 6863 6866 1:CAS:528:DC%2BD2cXotFalsrs%3D 10.1158/0008-5472.CAN-04-1804 15466174 (Pubitemid 39330992)
28. G Melino V De Laurenzi KH Vousden 2002 P73: friend or foe in tumorigenesis Nat Rev Cancer 2 605 615 1:CAS:528:DC%2BD38XlslGqs7Y%3D 10.1038/nrc861 12154353 (Pubitemid 37328927)
29. TJ Grob U Novak C Maisse, et al. 2001 Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53 Cell Death Differ 8 1213 1223 1:CAS:528:DC%2BD38XmtVKksg%3D%3D 10.1038/sj.cdd.4400962 11753569 (Pubitemid 34048476)
30. O Ishimoto C Kawahara K Enjo, et al. 2002 Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73 Cancer Res 62 636 641 1:CAS:528:DC%2BD38Xht1KrtLk%3D 11830511
31. T Stiewe CC Theseling BM Putzer 2002 Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis J Biol Chem 277 14177 14185 1:CAS:528:DC%2BD38XjsFWntLc%3D 10.1074/jbc.M200480200 11844800 (Pubitemid 34968030)
32. J Lööf D Pfeifer G Adell X-F Sun 2009 Significance of an exon 2 G4C14-to-A4T14 polymorphism in the p73 gene on survival in rectal cancer patients with or without preoperative radiotherapy Radiother Oncol 92 215 220 10.1016/j.radonc.2009.06.007 19581013
33. O Petrenko A Zaika UM Moll 2003 deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo Mol Cell Biol 23 5540 5555 1:CAS:528:DC%2BD3sXmt1Srtrs%3D 10.1128/MCB.23.16.5540-5555.2003 12897129 (Pubitemid 36957905)
34. B Fernandez-Garcia JP Vaque M Herreros-Villanueva, et al. 2007 p73 cooperates with Ras in the activation of MAP kinase signaling cascade Cell Death Differ 14 254 265 1:CAS:528:DC%2BD2sXkslCisg%3D%3D 10.1038/sj.cdd.4401945 16645632 (Pubitemid 46092228)
35. G Melino X Lu M Gasco T Crook RA Knight 2003 Functional regulation of p73 and p63: development of cancer Trends Biochem Sci 28 663 670 1:CAS:528:DC%2BD3sXpsVSksro%3D 10.1016/j.tibs.2003.10.004 14659698 (Pubitemid 37500901)
36. L Shan Q Yang M Nakamura, et al. 2001 Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas Mod Pathol 14 273 278 1:STN:280:DC%2BD3MzisFWjsw%3D%3D 10.1038/modpathol.3880302 11301342 (Pubitemid 32298911)